Study Assesses How Music Therapy May Improve Fine Motor Skills
A clinical study is assessing whether a specific type of rehabilitation therapy — called neurologic music therapy — may help…
Articles by Patricia Inácio, PhD
Trial Testing Ketamine as Dyskinesia Treatment Soon Enrolling Patients
A new Phase 2 clinical trial will test the psychedelic painkiller ketamine as a treatment for levodopa-induced dyskinesia in people…
Dosing Begins in Phase 1 Trial of AP-472, for Dyskinesia With Levodopa
A Phase 1 trial of AP-472, Appello Pharmaceutical‘s lead investigational therapy to ease levodopa-induced dyskinesia in Parkinson’s disease, has started…
Student Wins Fellowship to Study New Ways to Halt Brain Inflammation
A medical student at the University of Queensland has won a U.S. Parkinson’s Foundation fellowship to investigate new ways…
Financing Supports Planned US Trial of Lecigon for Advanced Parkinson’s
Intrance Medical Systems has raised $8 million to support a planned U.S. clinical trial of its fixed-dose combination of levodopa, carbidopa,…
Top-line Results Due by Year’s End for Just-completed P2B001 Trial
Top-line results are expected to be released by the end of this year for Pharma Two B’s multinational trial investigating the…
Analyses: Gocovri Works Better to Lessen Off Episodes, Dyskinesia
Several new clinical trial data analyses support the benefits and superiority of Gocovri (amantadine) over other therapies in lessening…
$75M Funding Will Help TreeFrog Develop Stem Cell Therapies
TreeFrog Therapeutics has raised $75 million in financing to support the clinical development of its stem cell-derived cell therapies…
Genetic Testing Costly, Hard to Access, Survey Shows
High prices, lack of access, and long waiting times are major barriers to people who want to undergo genetic testing…
No Need for Nausea Treatment for Most Patients on Kynmobi
The majority of Parkinson’s patients given Sunovion‘s Kynmobi (apomorphine hydrochloride) for “off” episodes during Phase 3 clinical trials…